The Changes of Growth Patterns and the Production of Brain-Derived Neurotrophic Factors (BDNFs) in Perfusion Cultivation of Human Neuroblastoma Cells

  • Hong, Jong-Soo (Division of Food and Biotechnology, Kangwon National University) ;
  • Lee, Joo-Nho (Division of Food and Biotechnology, Kangwon National University) ;
  • Kim, Sun-Hee (Division of Food and Biotechnology, Kangwon National University) ;
  • Park, Kyung-Yoo (Department of Medicine, Hallym University) ;
  • Cho, Jin-Sang (Department of Medicine, Hallym University) ;
  • Lee, Hyeon-Yong (Division of Food and Biotechnology, Kangwon National University)
  • Published : 1999.06.01

Abstract

It was shown that brain-derived neurotrophic factors (BDNFs) secreted from human neuroblastoma cells can significantly improve the growth of the neurites of PC12 nerve cells. The addition of purified BDNFs elongated the neurites of PC 12 nerve cells two to three times more than the case where the addition was not made. The perfusion rate strongly affected the change of the size of human neuroblastoma cells because the cell size decreased as the perfusion rate increased. This could also influence the productivity of BDNF from the cells. It is also important to note that the BDNF production was decreased when the cell size was reduced. BDNF production rate also decreased at a fast perfusion rate in a smaller cell size. At the relatively fast perfusion rate of 18 ml/h, the ratio of apoptotic to necrotic cells dramatically decreased, which possibly caused the decrease of BDNF production. It has been proven that the secretion of BDNF from human neuroblastoma cells was a partially growth-related process by yielding 6.2$\times l0^{-8}/g$ of BDNF/cell/h of growth related parameter and $0.48{\times}l0^{-9}/g$ of BDNF/cell/h of nongrowth-related parameter in a growth kinetic model. In addition, it was also found that the perfusion rate played a very important role in controlling the cell death mechanism.

Keywords

References

  1. Biotechnol. Bioeng. v.45 Death mechanism of animal cells in conditions of intensive agitation Al-Rubeai, M.;R. P. Singh;M. H. Goldman;A. N. Emery
  2. Ann. Neurol. v.29 Nerve growth factor prevents toxic neuropathy in mice Apfel, C. S.
  3. Biotechnol. Prog. v.10 A novel ultrasonic resonance field device for the retention of animal cells Burger, W.;M. Groschl;E. Benes
  4. Animal Cell Technology Butler, M.
  5. Throm. Haemat. v.66 A kinetic model of the circulatory regulation of tissue plasminogen activator Chandler, W. L.
  6. Cultivation of Animal Cells Frenshney, R. I.
  7. MS thesis. Kangwon National Univ Studies on the kinetics of producing brain-derived neurotrophic factor by mass cultivation of human neuroblastoma cells Hong, J. S.
  8. Proc. Natl. Acad. Sci. USA v.82 Cloning and expression of the human erythropoeitin gene Lin, F.K.;S. Suggs;C.H.Lin;J.F.Browne;R.Smalling;J.C. Ergie;L. J. Goldwasser
  9. Large Scale Cell Culture Technology Lyndresen, B.K.
  10. Bioprocess Engineering Michael, L. S.;F. Kargi
  11. Biotechnol. Bioeng. v.44 Cell cycle kinetics and monoclonal antibody production of hybridoma cells during perfusion culture Park, S. H.;D. Y. Ryu
  12. Endocrinology v.129 Primary structure and biological activity of the human brain-derived neurortophic factor Rosenthal, A.;D. V. Goeddel;T. Nguyen;E. Martin
  13. Brain Res. v.38 The quantitative bioassay of the nerve growth factor: Use of frozen primed PC12 pheochromacytoma cells Rukenstein, A.;L. A. Greene
  14. Animal Cell Technolohy: Products of today, Prospects for tommorrow Spier, R. E.;J. B. Griffiths;W. Berthold
  15. Pharm. Res. v.26 Neurotrophic factor: From physiology to pharmacology Vantini, G.;S. D. Skaper